Last reviewed · How we verify

NCT03510949

Nasopharyngeal Versus Laryngeal Mask Airway in Anaesthesia for Bilateral Blepharoplasty

Completed NA Last updated 3 July 2018
What this trial tests

NA trial testing Nasopharyngeal airway or laryngeal mask airway in Injury Throat in 148 participants. Completed in 1 July 2018.

Timeline
1 February 2018
Primary endpoint
1 July 2018
1 July 2018

Quick facts

Lead sponsorHala Salah El-Din El-Ozairy
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment148
Start date1 February 2018
Primary completion1 July 2018
Estimated completion1 July 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Hala Salah El-Din El-Ozairy

Who can join

Adults 40 to 60, any sex, with Injury Throat. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

General anaesthesia demands securing patient's airway either with endotracheal tube or laryngeal mask (LMA); however, both carry the disadvantage of postoperative soar throat. Nasopharyngeal airway (NPA) can be an alternative without the risk of postoperative soar throat.6 The primary end point of our study is to assess the incidence of soar throat with the use of NPA compared to LMA in patients receiving general anaesthesia during blepharoplasty.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison between nasopharyngeal airway and laryngeal mask airway in blepharoplasty under general anaesthesia. A randomized controlled trial.
    El-Ozairy HSE, Abd-Elmaksoud AM, El-Hennawy AM. · · 2020 · cited 4× · PMID 33327697 · DOI 10.5114/ait.2020.101412

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03510949.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing